Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differential Regulation of VEGF, Cadherin and Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors: Try to Explain the Lower OHSS Incidence

NCT00848185 is registered in ClinicalTrials.gov with IVI Madrid as lead sponsor.

NCT NCT00848185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differential Regulation of VEGF, Cadherin and Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors: Try to Explain the Lower OHSS Incidence
Lead sponsor
IVI Madrid
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2009
Enrollment
96 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vascular endothelial growth factor overexpression